Cite

HARVARD Citation

    Tersteeg, C. et al. (2015). Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura. Arteriosclerosis, thrombosis, and vascular biology. 35 (11), p. . [Online]. 
  
Back to record